Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study.

Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study. — المؤلف: Yamamura, Jun — In vivo (Athens, Greece) 20190404

المؤلف
Yamamura, Jun
النشر
In vivo (Athens, Greece) 20190404
الوصف
281-287 p.
الموضوعات
Adult؛ Aged؛ Biomarkers, Tumor؛ Breast Neoplasms؛ Disease-Free Survival؛ Female؛ Humans؛ Liver Neoplasms